The Fatally Slow Quest for Next-Gen Antibiotics.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      ANTIBIOTICS; DRUG resistance in bacteria
    • Abstract:
      Although Dudley, a San Diego Pharm.D. and infectious-disease specialist, knew all about out-of-control infections that could kill even healthy patients, his brother-inlaw's death was a stark reminder that they can turn so deadly so fast, overwhelming the antibiotics we have to try to stop them. Big Pharma has abandoned the highly unprofitable antibiotic business in favor of more revenue-generating drugs for chronic diseases. By doing this with drug after drug, we've created "superbugs" that can be invulnerable to any antibiotic on the market. The approval of the drug was also a personal victory for Dudley, who was inspired to enter the drug-development business after witnessing the suffering of people with AIDS when no treatments were available. [Extracted from the article]
    • Abstract:
      Copyright of Men's Health is the property of Hearst Magazines, a division of Hearst Communications, Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)